- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01887392
Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL) (GOAL)
The Evaluation of a Multifaceted, Knowledge Translation Education Intervention in Long-Term Care and Its Ability to Facilitate the Uptake of Osteoporosis Canada 2010 Clinical Practice Guidelines, Across Ontario LTC Homes
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Individuals who live in LTC are at high risk for osteoporosis and fractures, particularly hip fractures, which lead to pain and transfer to acute care. The investigators' previous work in LTC has shown that awareness and use of clinical practice guidelines in LTC are low. To successfully transfer knowledge, it is imperative to understand the needs of the LTC teams and to tailor KT interventions appropriately.
Interventions which focus on strategies to overcome barriers and on new ways to deliver and promote the uptake of best practices that are specific to both the learning needs of LTC health care providers and the operational/organizational culture in LTC are greatly needed. Interdisciplinary teams who participated in the Vitamin D and Osteoporosis Study (ViDOS) indicated several process barriers that may hinder the proper identification and treatment of fractures in LTC. There is a need to educate Ontario LTC practitioners on the osteoporosis guidelines. The investigators' aim is to facilitate the uptake of Osteoporosis Canada 2010 Clinical Practice Guidelines, across Ontario LTC homes using the ViDOS multi-faceted KT model. Furthermore, the investigators will have a greater emphasis on the implementation of guidelines which includes risk assessment and appropriate medication use.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8M 1W9
- St. Peter's Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- A minimum of 2 physicians for each LTC home served by a Pharmacy provider
Exclusion Criteria:
- LTC homes that have only one prescribing physician
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Wave A
LTC Homes randomized into Wave A will receive the intervention first.
The intervention includes Knowledge Translation Education Sessions.
|
Two interactive sessions will be delivered to the interprofessional team at Month 1 and Month 6 and are 1 hour in length.
The Clinical Consultant Pharmacist at each LTC home will lead the Knowledge Translation Sessions.
Participants will watch an educational video, developed by the co-investigators with expertise in osteoporosis and geriatrics and members of the Ontario College of Family Physicians.
Accompanying materials that support the topics in the video will be provided.
Following the educational video, one of the experts from the video will phone the LTC home to address questions and provide the home with direct access to an expert.
|
Experimentell: Wave B
LTC Homes randomized into Wave B will receive the intervention after Wave A. The intervention includes Knowledge Translation Education Sessions.
|
Two interactive sessions will be delivered to the interprofessional team at Month 1 and Month 6 and are 1 hour in length.
The Clinical Consultant Pharmacist at each LTC home will lead the Knowledge Translation Sessions.
Participants will watch an educational video, developed by the co-investigators with expertise in osteoporosis and geriatrics and members of the Ontario College of Family Physicians.
Accompanying materials that support the topics in the video will be provided.
Following the educational video, one of the experts from the video will phone the LTC home to address questions and provide the home with direct access to an expert.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Difference in the percentage of residents appropriately prescribed an osteoporosis medication before and after the intervention.
Tidsram: 18 months
|
Difference in the percentage of residents appropriately prescribed an osteoporosis medication before and after the intervention will be measured.
Medications to be included in the baseline and post data download are in accordance with the current Osteoporosis Canada guidelines.
Treatment is considered appropriate for an individual over age 50 who has had a diagnosis of osteoporosis or a fragility fracture of the hip or vertebra and those who have had more than one fragility fracture (i.e.
high risk).
|
18 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Difference in the percentage of residents prescribed Vitamin D (equivalent to ≥800 IU/day) before and after the intervention.
Tidsram: 18 months
|
Vitamin D will be included in the baseline and post data download to compare the two results and see if more residents have been prescribed vitamin D.
|
18 months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Alexandra Papaioannou, MD, MSc, McMaster University
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- REB 13-229
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Knowledge Translation Education Sessions
-
Istituti Clinici Scientifici Maugeri SpAIndragen
-
NYU Langone HealthIndragen
-
Virginia Commonwealth UniversityNational Institute on Minority Health and Health Disparities (NIMHD)AvslutadHIV-infektioner | SubstansanvändningFörenta staterna